FALSINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 1.949
EU - Europa 979
AS - Asia 720
SA - Sud America 90
AF - Africa 14
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.767
Nazione #
US - Stati Uniti d'America 1.922
RU - Federazione Russa 408
SG - Singapore 180
CN - Cina 169
HK - Hong Kong 146
IT - Italia 131
IE - Irlanda 128
PL - Polonia 105
SE - Svezia 89
VN - Vietnam 76
BR - Brasile 70
KR - Corea 57
IN - India 37
DE - Germania 31
GB - Regno Unito 23
JO - Giordania 21
ES - Italia 20
CA - Canada 18
AR - Argentina 11
FI - Finlandia 11
ID - Indonesia 11
AU - Australia 10
FR - Francia 9
NL - Olanda 8
JP - Giappone 7
MX - Messico 6
UA - Ucraina 6
BE - Belgio 4
EU - Europa 4
TR - Turchia 4
CI - Costa d'Avorio 3
IQ - Iraq 3
PE - Perù 3
PK - Pakistan 3
ZA - Sudafrica 3
BD - Bangladesh 2
EC - Ecuador 2
EG - Egitto 2
MA - Marocco 2
PY - Paraguay 2
SN - Senegal 2
AL - Albania 1
BY - Bielorussia 1
BZ - Belize 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EE - Estonia 1
JM - Giamaica 1
KE - Kenya 1
LT - Lituania 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 3.767
Città #
Santa Clara 560
Ashburn 216
Fairfield 149
Chandler 141
Dublin 128
Hong Kong 127
Warsaw 105
Singapore 100
Woodbridge 74
Houston 73
Seattle 67
Cambridge 62
Wilmington 58
Seoul 55
Beijing 54
Florence 47
Dong Ket 40
Ann Arbor 36
Mumbai 30
Princeton 29
Los Angeles 25
Altamura 23
Lawrence 23
Clifton 22
Shanghai 20
Barcelona 17
New York 17
Boston 15
Moscow 14
Munich 14
Buffalo 13
Ho Chi Minh City 13
Hefei 12
Falls Church 11
Jakarta 11
Medford 11
Dallas 10
San Diego 10
Gavirate 9
Melbourne 9
Kent 8
Boardman 7
Cagliari 7
Hanoi 7
Guangzhou 6
Jacksonville 6
London 6
Paris 6
Redondo Beach 6
The Dalles 6
Brooklyn 5
San Francisco 5
Brussels 4
City of London 4
Jinan 4
Parma 4
Tianjin 4
Tokyo 4
Toronto 4
Abidjan 3
Atlanta 3
Chicago 3
Council Bluffs 3
Curitiba 3
Helsinki 3
Norwalk 3
Orem 3
Pontassieve 3
Pune 3
Querétaro 3
Stockholm 3
São Paulo 3
Ankara 2
Buenos Aires 2
Camerino 2
Casablanca 2
Dakar 2
Denver 2
Ferrara 2
Haiphong 2
Hillsboro 2
Icheon-si 2
Ipatinga 2
Islamabad 2
Johannesburg 2
Lima 2
Nanjing 2
Poplar 2
Quito 2
Redwood City 2
Ribeirão Preto 2
Rio de Janeiro 2
Shenzhen 2
Stia 2
Thái Nguyên 2
Trumbull 2
Turku 2
Vancouver 2
Vĩnh Phúc Province 2
West Jordan 2
Totale 2.648
Nome #
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor Subtype 252
Design and synthesis of new adenosine receptor antagonists as neuroprotective agents 206
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 194
3-Hydroxy-1H-quinazoline-2,4-dione as a New Scaffold to Develop Potent and Selective Inhibitors of the Tumor-Associated Carbonic Anhydrases IX and XII 190
Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII 186
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 181
Development of novel pyridazinone-based adenosine receptor ligands 171
Modifications on the Amino-3,5-dicyanopyridine Core To Obtain Multifaceted Adenosine Receptor Ligands with Antineuropathic Activity 169
Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain 168
Design, synthesis, and pharmacological characterization of 2‑(2- furanyl)thiazolo[5,4‑d]pyrimidine-5,7-diamine derivatives: new highly potent A2A adenosine receptor inverse agonists with antinociceptive activity 165
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 165
New 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives. Evaluation of different moieties on the 6-aryl ring to obtain potent and selective human A2A adenosine receptor antagonists 154
Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity 150
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2Breceptor 148
2-Aryl-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as new potent adenosine human A2A receptor antagonists 145
Novel 8-amino-1,2,4-triazolo[4,3-a]pyrazin-3-one derivatives as potent human adenosine A 1 and A 2A receptor antagonists. Evaluation of their protective effect against β-amyloid-induced neurotoxicity in SH-SY5Y cells 145
3-Hydroxy-1H-quinazoline-2,4-dione derivatives as new potent and selective inhibitors of the tumor-associated carbonic anhydrase IX and XII. 137
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 136
Aminopyridine-3,5-carbonitrile core for the design of new adenosine receptor agonists: structural exploration to target the A1 subtype 126
Thiazolo[5,4-d]pyrimidin-7-amino derivatives as dual human adenosine A2A/A1 receptor antagonists. 118
Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A1and A2Aadenosine receptor antagonists/inverse agonists 118
New 5-heteroaryl-pyrazolo[4,3-d]pyrimidin-7-amines as dual human adenosine A1 and A2A receptor antagonists. 117
New aminopyridine-3,5-dicarbonitirles as adenosine A2B receptor non-nucleoside agonists. 113
Structure-activity relationship studies and pharmacological characterization of N5-heteroarylalkyl-substituted-2-(2-furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine-based derivatives as inverse agonists at human A2Aadenosine receptor 111
Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A2A Receptor 72
Totale 3.837
Categoria #
all - tutte 10.850
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.850


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 14 7 16 33 48 22 43
2021/2022185 6 12 27 4 6 8 7 13 6 17 30 49
2022/2023522 43 90 45 30 36 96 62 44 56 0 15 5
2023/2024219 5 20 23 10 7 53 9 48 10 18 10 6
2024/20251.347 30 151 71 152 440 213 14 86 62 40 53 35
2025/2026726 175 177 64 130 163 17 0 0 0 0 0 0
Totale 3.837